1. Home
  2. EVCM vs ANIP Comparison

EVCM vs ANIP Comparison

Compare EVCM & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVCM
  • ANIP
  • Stock Information
  • Founded
  • EVCM 2006
  • ANIP 2001
  • Country
  • EVCM United States
  • ANIP United States
  • Employees
  • EVCM N/A
  • ANIP N/A
  • Industry
  • EVCM EDP Services
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVCM Technology
  • ANIP Health Care
  • Exchange
  • EVCM Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • EVCM 1.7B
  • ANIP 1.4B
  • IPO Year
  • EVCM 2021
  • ANIP N/A
  • Fundamental
  • Price
  • EVCM $10.65
  • ANIP $64.96
  • Analyst Decision
  • EVCM Buy
  • ANIP Strong Buy
  • Analyst Count
  • EVCM 12
  • ANIP 9
  • Target Price
  • EVCM $11.67
  • ANIP $80.56
  • AVG Volume (30 Days)
  • EVCM 258.1K
  • ANIP 262.3K
  • Earning Date
  • EVCM 08-05-2025
  • ANIP 08-05-2025
  • Dividend Yield
  • EVCM N/A
  • ANIP N/A
  • EPS Growth
  • EVCM N/A
  • ANIP N/A
  • EPS
  • EVCM N/A
  • ANIP N/A
  • Revenue
  • EVCM $703,186,000.00
  • ANIP $674,068,000.00
  • Revenue This Year
  • EVCM N/A
  • ANIP $30.84
  • Revenue Next Year
  • EVCM $6.31
  • ANIP $7.39
  • P/E Ratio
  • EVCM N/A
  • ANIP N/A
  • Revenue Growth
  • EVCM 7.84
  • ANIP 30.27
  • 52 Week Low
  • EVCM $8.10
  • ANIP $52.50
  • 52 Week High
  • EVCM $12.35
  • ANIP $77.00
  • Technical
  • Relative Strength Index (RSI)
  • EVCM 58.09
  • ANIP 52.40
  • Support Level
  • EVCM $10.53
  • ANIP $63.17
  • Resistance Level
  • EVCM $10.88
  • ANIP $66.97
  • Average True Range (ATR)
  • EVCM 0.30
  • ANIP 1.79
  • MACD
  • EVCM 0.06
  • ANIP -0.01
  • Stochastic Oscillator
  • EVCM 79.67
  • ANIP 42.12

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: